Annual ROE
25.26%
-68.11%-72.95%
December 31, 2024
Summary
- As of March 10, 2025, MDXG annual return on equity is 25.26%, with the most recent change of -68.11% (-72.95%) on December 31, 2024.
- During the last 3 years, MDXG annual ROE has risen by +15.03 thousand% (+100.17%).
- MDXG annual ROE is now -84.95% below its all-time high of 167.87%, reached on December 31, 2022.
Performance
MDXG ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
25.23%
-42.94%-62.99%
December 31, 2024
Summary
- As of March 10, 2025, MDXG quarterly return on equity is 25.23%, with the most recent change of -42.94% (-62.99%) on December 31, 2024.
- Over the past year, MDXG quarterly ROE has dropped by -109.39% (-81.26%).
- MDXG quarterly ROE is now -95.41% below its all-time high of 550.08%, reached on September 30, 2021.
Performance
MDXG Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
MDXG ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -73.0% | -81.3% |
| 3 y3 years | +100.2% | -81.3% |
| 5 y5 years | +141.5% | -81.3% |
MDXG ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -85.0% | +100.2% | -92.8% | +168.8% |
| 5 y | 5-year | -85.0% | +100.2% | -95.4% | +102.2% |
| alltime | all time | -85.0% | +100.2% | -95.4% | +102.2% |
MiMedx ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | 25.26%(-72.9%) | 25.23%(-63.0%) |
| Sep 2024 | - | 68.17%(-30.2%) |
| Jun 2024 | - | 97.66%(-27.5%) |
| Mar 2024 | - | 134.62%(-55.9%) |
| Dec 2023 | 93.37%(-44.4%) | 305.03%(-931.1%) |
| Sep 2023 | - | -36.70%(-149.5%) |
| Jun 2023 | - | 74.12%(-48.2%) |
| Mar 2023 | - | 143.02%(-30.7%) |
| Dec 2022 | 167.87%(-101.1%) | 206.32%(-29.4%) |
| Sep 2022 | - | 292.37%(-16.7%) |
| Jun 2022 | - | 351.19%(+23.7%) |
| Mar 2022 | - | 283.94%(+20.7%) |
| Dec 2021 | -15.00 K%(+5112.2%) | 235.27%(-57.2%) |
| Sep 2021 | - | 550.08%(-148.6%) |
| Jun 2021 | - | -1131.77%(+147.9%) |
| Mar 2021 | - | -456.60%(+85.9%) |
| Dec 2020 | -287.81%(+372.8%) | -245.64%(+71.2%) |
| Sep 2020 | - | -143.46%(+419.6%) |
| Jun 2020 | - | -27.61%(-46.0%) |
| Mar 2020 | - | -51.17%(-25.3%) |
| Dec 2019 | -60.87%(+25.3%) | -68.52%(-43.0%) |
| Sep 2019 | - | -120.16%(+18.2%) |
| Jun 2019 | - | -101.66%(+91.8%) |
| Mar 2019 | - | -53.01%(+91.8%) |
| Dec 2018 | -48.57%(-177.6%) | -27.64%(-149.6%) |
| Sep 2018 | - | 55.72%(+2.6%) |
| Jun 2018 | - | 54.33%(+1.2%) |
| Mar 2018 | - | 53.66%(+3.7%) |
| Dec 2017 | 62.60%(>+9900.0%) | 51.73%(+194.1%) |
| Sep 2017 | - | 17.59%(+139.3%) |
| Jun 2017 | - | 7.35%(+159.7%) |
| Mar 2017 | - | 2.83%(+784.4%) |
| Dec 2016 | 0.32%(-98.9%) | 0.32%(-98.2%) |
| Sep 2016 | - | 17.50%(-18.6%) |
| Jun 2016 | - | 21.49%(-18.7%) |
| Mar 2016 | - | 26.43%(-14.3%) |
| Dec 2015 | 29.85% | 30.83%(+39.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | 22.08%(+10.0%) |
| Jun 2015 | - | 20.07%(+45.8%) |
| Mar 2015 | - | 13.77%(+74.7%) |
| Dec 2014 | 7.64%(-186.9%) | 7.88%(+458.9%) |
| Sep 2014 | - | 1.41%(-127.1%) |
| Jun 2014 | - | -5.20%(-23.9%) |
| Mar 2014 | - | -6.83%(-35.7%) |
| Dec 2013 | -8.79%(-81.7%) | -10.62%(-31.1%) |
| Sep 2013 | - | -15.41%(-55.2%) |
| Jun 2013 | - | -34.37%(-16.9%) |
| Mar 2013 | - | -41.38%(-14.4%) |
| Dec 2012 | -48.04%(-57.6%) | -48.35%(-20.4%) |
| Sep 2012 | - | -60.72%(+27.4%) |
| Jun 2012 | - | -47.66%(-26.1%) |
| Mar 2012 | - | -64.50%(-30.2%) |
| Dec 2011 | -113.28%(-39.6%) | -92.40%(-12.5%) |
| Sep 2011 | - | -105.62%(-16.2%) |
| Jun 2011 | - | -126.07%(-13.6%) |
| Mar 2011 | - | -145.96%(-23.4%) |
| Dec 2010 | -187.63%(-6.9%) | -190.61%(+55.9%) |
| Sep 2010 | - | -122.23%(-28.4%) |
| Jun 2010 | - | -170.65%(-30.1%) |
| Mar 2010 | - | -244.11%(-44.2%) |
| Dec 2009 | -201.64%(-63.5%) | - |
| Sep 2009 | - | -437.78%(+54.7%) |
| Jun 2009 | - | -282.97%(+45.7%) |
| Mar 2009 | - | -194.23%(+60.2%) |
| Mar 2009 | -552.79%(+352.8%) | - |
| Dec 2008 | - | -121.22%(+8.7%) |
| Sep 2008 | - | -111.52%(+32.0%) |
| Jun 2008 | - | -84.46%(-153.1%) |
| Mar 2008 | -122.08%(-211.7%) | - |
| Dec 2007 | 109.27%(-121.6%) | 158.94%(+7.2%) |
| Sep 2007 | - | 148.31%(+2.4%) |
| Jun 2007 | - | 144.83%(+15.3%) |
| Mar 2007 | - | 125.58% |
| Dec 2006 | -506.06% | - |
FAQ
- What is MiMedx annual return on equity?
- What is the all time high annual ROE for MiMedx?
- What is MiMedx annual ROE year-on-year change?
- What is MiMedx quarterly return on equity?
- What is the all time high quarterly ROE for MiMedx?
- What is MiMedx quarterly ROE year-on-year change?
What is MiMedx annual return on equity?
The current annual ROE of MDXG is 25.26%
What is the all time high annual ROE for MiMedx?
MiMedx all-time high annual return on equity is 167.87%
What is MiMedx annual ROE year-on-year change?
Over the past year, MDXG annual return on equity has changed by -68.11% (-72.95%)
What is MiMedx quarterly return on equity?
The current quarterly ROE of MDXG is 25.23%
What is the all time high quarterly ROE for MiMedx?
MiMedx all-time high quarterly return on equity is 550.08%
What is MiMedx quarterly ROE year-on-year change?
Over the past year, MDXG quarterly return on equity has changed by -109.39% (-81.26%)